Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Differential effects of donepezil vs placebo on EEG/ERP and fMRI in amnestic mild cognitive impairment and elderly controls
2009-011582-88Phase 2Terminated
- Sponsor
- St James's Hospital
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in amnestic mild cognitive impairment (MCI) and confusion comparing Donepezil arm with Placebo arm (2 arms). Primary endpoints: P3a ERP amplitude change and P3a ERP latency change. Started Apr 2009; status: terminated.
02
Drugs
donepezil
03
Conditions
amnestic mild cognitive impairment (MCI)confusion
Beyond the preview
Go deeper on 2009-011582-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011582-88.